A SYSTEMATIC REVIEW OF QUALITY OF LIFE ASSESSMENT OF PATIENTS SUFFERING FROM THORACIC AORITC DISEASES
Author(s)
Brasseur P1, Sidhu R21Medtronic International SA, Tolochenaz, Vaud, Switzerland, 2LSE, London, United Kingdom
OBJECTIVES: To review studies assessing the quality of life associated with thoracic aortic diseases (TADs) and their treatment with Open Aortic Repair (OAR), Thoracic Endovascular Aortic Repair (TEVAR) or medical management (MM). METHODS: PubMed and EMBASE were searched covering terms related to TADs and patient reported outcomes/quality of life. The search was limited to articles in English and to studies relating to humans. However, no time period was specified so as to enable a broad search. The studies obtained were analysed qualitatively. RESULTS: : Eight studies met the review criteria. Published 1998 and 2009, four dealt with aneurysms, two with dissections and two with more than one of the TADs; all of them were based on assesment of quality of life after treatment rather than on the disease itself. Only one study covered emergency versus elective surgery. The number of patients was very small in all studies, ranging from 75 to 11. Mean follow-up varied from 7 to 76 months. The most commonly used instrument was the SF-36. Two studies also used the Hospital Anxiety and Depression Score (HADS) in addition to the SF-36. One study adopted the SWEDQUAL questionnaire ; another study had recourse to the Illness Intrusiveness Rating Scale (IIRS) and the Karnofsky Activity Scale (KAS), which lacked information on proper validation for this target population. All in all, none of the study conducted the quality of life assessment appropriately, particularly with regard to the follow-up period, the lack of pre-operative assessment and lack of direct comparison between interventions. Lastly, there were no utility assessments to be found, which would be essential to arrive at QALY values and thus take the process of economic analysis forward. CONCLUSIONS: The studies available so far do not provide evidence of the quality of life associated with TADs, as well as conclusive evidence of the quality of life associated with OAR; TEVAR and/or MM.
Conference/Value in Health Info
2010-05, ISPOR 2010, Atlanta, GA, USA
Value in Health, Vol. 13, No. 3 (May 2010)
Code
PCV115
Topic
Patient-Centered Research
Topic Subcategory
Patient-reported Outcomes & Quality of Life Outcomes
Disease
Cardiovascular Disorders, Respiratory-Related Disorders